TREM2 and Alzheimer disease: The R47H variant of triggering receptor expressed on myeloid cells 2 (TREM2), a transmembrane protein that is reported to be associated with late-onset AD progression [202], was recently found to have an altered N-glycoprofile in comparison to the wild type.